PP487
PP487 is a selective dual inhibitor of Tyrosine kinase/PI3-K, with IC50 values of 0.017 μM, 0.072 μM, 0.004 μM, 0.01 μM, 0.55 μM, 0.22 μM, and < 0.01 μM against DNA-PK, mTOR, Hck, Src, EGFR, EphB4, and PDGFR, respectively. PP487 can be used in cancer research.
For research use only. We do not sell to patients.
- CAS No.: 1092787-12-6
- Formula: C14H14BrN5O
- Molecular Weight:348.20
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
p110α 0.046 μM (IC50) |
p110β 0.24 μM (IC50) |
p110δ 0.027 μM (IC50) |
p110γ 0.1 μM (IC50) |
Abl 0.021 μM (IC50) |
VEGFR2 0.055 μM (IC50) |
In Vitro
PP487 (0.001-50 µM) potently inhibits nanomolar-concentration tyrosine kinases (including Src) as well as members of the PI3-K family (including mTOR), while maintaining high selectivity toward the serine-threonine kinase panel[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1092787-12-6
-
Molecular Weight 348.20
-
Formula C14H14BrN5O
-
SMILES
BrC1=C(O)C=C(C2=NN(C(C)C)C3=C2C(N)=NC=N3)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- PP487
- 1092787-12-6
- PP 487
- PP-487
- c-Met/HGFR
- PI3K
- DNA-PK
- mTOR
- Bcr-Abl
- Src
- VEGFR
- EGFR
- PDGFR
- Phosphoinositide 3-kinase
- DNA-dependent protein kinase
- Mammalian target of Rapamycin
- Vascular endothelial growth factor receptor
- Epidermal growth factor receptor
- ErbB-1
- HER1
- Platelet-derived growth factor receptor
- Abl
- serine-threonine kinome
- VEGF receptor
- p110α
- PI3-K family members
- tyrosine kinases
- Inhibitor
- inhibitor
- inhibit